• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/04/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer stated that they have received erroneous results for a total of 5 samples from the same patient tested for creatinine plus ver.2 (crep) on a c501 analyzer.All sample results were reported outside of the laboratory to the physician.No alarms occurred on the analyzer.It was stated that the blood samples were collected from an infusion port where dopamine was administered.It was stated that samples were collected 15 minutes after an infusion is stopped.(b)(6).The patient was not adversely affected.The c501 analyzer serial number was (b)(4).
 
Manufacturer Narrative
A specific root cause could not be determined based on the provided information.Based upon the information provided, calibration and quality controls are acceptable.A general reagent or hardware issue could be excluded.The patient sample was collected from the same intravenous catheter in which dopamine was administered.Investigations have determined that high catecholamine concentrations can lead to falsely low crep results.Dopamine and dobutamine at unusually high concentrations may interfere with peroxide based tests.In cases when high dosages of catecholamines are administered, no relevant interference could be found if the blood sample was not taken near the location of administration of catecholamine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5761446
MDR Text Key48528654
Report Number1823260-2016-00833
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03263991190
Device Lot Number115655
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received06/06/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age86 YR
-
-